vs

Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and RMR GROUP INC. (RMR). Click either name above to swap in a different company.

RMR GROUP INC. is the larger business by last-quarter revenue ($66.7M vs $38.3M, roughly 1.7× ImmunityBio, Inc.). RMR GROUP INC. runs the higher net margin — 18.3% vs -161.8%, a 180.1% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 40.8%).

ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.

RMR Group Inc. is a U.S.-headquartered alternative asset management firm specializing in real estate and real estate-related investments. It operates across commercial property, residential real estate, and infrastructure segments, serving institutional investors, high-net-worth individuals, and retail clients across key global markets.

IBRX vs RMR — Head-to-Head

Bigger by revenue
RMR
RMR
1.7× larger
RMR
$66.7M
$38.3M
IBRX
Growing faster (revenue YoY)
IBRX
IBRX
+366.2% gap
IBRX
407.0%
40.8%
RMR
Higher net margin
RMR
RMR
180.1% more per $
RMR
18.3%
-161.8%
IBRX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IBRX
IBRX
RMR
RMR
Revenue
$38.3M
$66.7M
Net Profit
$-61.9M
$12.2M
Gross Margin
99.0%
Operating Margin
-169.0%
48.1%
Net Margin
-161.8%
18.3%
Revenue YoY
407.0%
40.8%
Net Profit YoY
-4.7%
91.1%
EPS (diluted)
$-0.06
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBRX
IBRX
RMR
RMR
Q4 25
$38.3M
$66.7M
Q3 25
$32.1M
Q2 25
$26.4M
Q1 25
$16.5M
Q4 24
$7.6M
Q3 24
$6.1M
Net Profit
IBRX
IBRX
RMR
RMR
Q4 25
$-61.9M
$12.2M
Q3 25
$-67.3M
Q2 25
$-92.6M
Q1 25
$-129.6M
Q4 24
$-59.2M
Q3 24
$-85.7M
Gross Margin
IBRX
IBRX
RMR
RMR
Q4 25
99.0%
Q3 25
99.4%
Q2 25
99.5%
Q1 25
99.6%
Q4 24
Q3 24
Operating Margin
IBRX
IBRX
RMR
RMR
Q4 25
-169.0%
48.1%
Q3 25
-173.5%
Q2 25
-269.8%
Q1 25
-390.1%
Q4 24
-919.0%
Q3 24
-1314.3%
Net Margin
IBRX
IBRX
RMR
RMR
Q4 25
-161.8%
18.3%
Q3 25
-209.8%
Q2 25
-350.3%
Q1 25
-784.9%
Q4 24
-783.4%
Q3 24
-1404.0%
EPS (diluted)
IBRX
IBRX
RMR
RMR
Q4 25
$-0.06
$0.71
Q3 25
$-0.07
Q2 25
$-0.10
Q1 25
$-0.15
Q4 24
$-0.08
Q3 24
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBRX
IBRX
RMR
RMR
Cash + ST InvestmentsLiquidity on hand
$242.8M
$49.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-500.5M
$232.7M
Total Assets
$501.9M
$687.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBRX
IBRX
RMR
RMR
Q4 25
$242.8M
$49.3M
Q3 25
$257.8M
Q2 25
$153.7M
Q1 25
$61.6M
Q4 24
$149.8M
Q3 24
$130.4M
Stockholders' Equity
IBRX
IBRX
RMR
RMR
Q4 25
$-500.5M
$232.7M
Q3 25
$-524.3M
Q2 25
$-570.7M
Q1 25
$-591.4M
Q4 24
$-489.1M
Q3 24
$-745.1M
Total Assets
IBRX
IBRX
RMR
RMR
Q4 25
$501.9M
$687.1M
Q3 25
$519.0M
Q2 25
$402.1M
Q1 25
$303.8M
Q4 24
$382.9M
Q3 24
$364.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBRX
IBRX
RMR
RMR
Operating Cash FlowLast quarter
$-70.4M
$10.7M
Free Cash FlowOCF − Capex
$-71.3M
FCF MarginFCF / Revenue
-186.2%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters
$-308.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBRX
IBRX
RMR
RMR
Q4 25
$-70.4M
$10.7M
Q3 25
$-68.9M
Q2 25
$-79.7M
Q1 25
$-85.9M
Q4 24
$-85.1M
Q3 24
$-98.8M
Free Cash Flow
IBRX
IBRX
RMR
RMR
Q4 25
$-71.3M
Q3 25
$-69.6M
Q2 25
$-80.8M
Q1 25
$-87.0M
Q4 24
$-87.3M
Q3 24
$-101.6M
FCF Margin
IBRX
IBRX
RMR
RMR
Q4 25
-186.2%
Q3 25
-217.2%
Q2 25
-305.9%
Q1 25
-526.9%
Q4 24
-1155.4%
Q3 24
-1663.2%
Capex Intensity
IBRX
IBRX
RMR
RMR
Q4 25
2.4%
Q3 25
2.3%
Q2 25
4.1%
Q1 25
6.8%
Q4 24
28.0%
Q3 24
45.7%
Cash Conversion
IBRX
IBRX
RMR
RMR
Q4 25
0.88×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBRX
IBRX

Segment breakdown not available.

RMR
RMR

Management Service Incentive$23.6M35%
Industrial Logistics Properties Trust$15.1M23%
Managed Private Real Estate Capital$11.1M17%
Office Properties Income Trust$5.6M8%
Other Private Entities$5.3M8%
RMR Residential$3.4M5%
Sonesta International Hotels Corporation$2.1M3%
Investment Advisory Management And Administrative Service$1.2M2%

Related Comparisons